Navigation Links
Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance
Date:3/12/2010

in the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding our plans and goals, the expected properties and benefits of RDEA594, RDEA684, RDEA119, RDEA806, RDEA427 and our other compounds, the timing and results of our preclinical, clinical and other studies, the sufficiency of our cash resources and our financial performance. Risks that contribute to the uncertain nature of the forward-looking statements include risks related to the outcome of preclinical and clinical studies, risks related to regulatory approvals, delays in commencement of preclinical and clinical studies, costs associated with our drug discovery and development programs and risks related to the outcome of our business development activities, including collaboration or licensing agreements. These and other risks and uncertainties are described more fully in our most recently filed SEC documents, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, under the headings "Risk Factors." All forward-looking statements contained in this press release speak only as of the date on which they were made. We undertake no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

(Logo: http://www.n
'/>"/>

SOURCE Ardea Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
2. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
3. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
4. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
5. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
6. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
7. Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
8. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
9. Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
10. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
11. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  InMed Pharmaceuticals ... stage biopharmaceutical company that specializes in developing safer, ... of Paul C. Anderson , Ph.D., to ... pharma industry veteran who brings significant drug discovery ... Anderson is a synthetic organic chemist by training ...
(Date:3/31/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) ... and 300mg oral tablets, indicated for use in the ... Propafenone Hydrochloride 150mg, 225mg and 300mg tablets was $14 ... Arthur S. Przybyl , President and Chief Executive Officer ... our fourth product from the portfolio of approved generic ...
(Date:3/31/2015)... March 31, 2015  Oxis International, Inc. (OXIS) (OXI.PA) ... and commercialization, announced today Oxis CEO Tony Cataldo ... Oxis common shares on the Euronext exchange. Oxis shares ... symbol OXIS.   Oxis Chairman and CEO ... move forward with its strategies launched in 2014 and ...
Breaking Medicine Technology:InMed Pharmaceuticals Strengthens Scientific Advisory Board 2InMed Pharmaceuticals Strengthens Scientific Advisory Board 3InMed Pharmaceuticals Strengthens Scientific Advisory Board 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Oxis International Inc. Announces Request for Euronext Trading Suspension 2
... Oct. 7 Cleveland Clinic,s Top 10 Medical Innovations for ... therapies that are being developed to treat everything from deafness ... The list of breakthrough devices and therapies was selected by ... was unveiled during Cleveland Clinic,s 2009 Medical Innovation ...
... Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX ) today ... offering of 3.97 million shares of its common stock to ... gross proceeds of $3.97 million. , The shares were ... with the Securities and Exchange Commission that was declared effective ...
Cached Medicine Technology:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 2Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 3Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 4Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering 2
(Date:3/31/2015)... Dr. Parsa Mohebi, founder of Parsa Mohebi Hair ... the forefront of using beard hair to fill in ... a novelty has now become an absolute option for giving patients ... really do believe that beard to scalp hair transplant can be ... area isn’t as dense as we would like it,” says Dr. ...
(Date:3/31/2015)... CT (PRWEB) March 31, 2015 Calling all ... against Lyme and other tick-borne diseases! The first annual “Lyme ... Cove Island Park in Stamford, CT. The event, hosted by ... (TBDA), will raise funds to support research and education ... event, open to all ages and abilities, will feature 5K ...
(Date:3/31/2015)... 2015 OnChip Devices , a world ... silicon ESD diode chip targeted towards low voltage LED applications. ... Zeners are ideal for protecting circuits by suppressing voltage higher ... handle pulses of up to 350W and 20A, providing protection ... 61000-4-2 standard. These diodes do not exhibit any device ...
(Date:3/31/2015)... Scotch Plains, NJ (PRWEB) March 31, 2015 ... a board certified dermatologist by the American Board ... surgeon. After extensive dermatology research training at the ... Health, Dr. Li completed his internship in internal ... at the University of Pennsylvania in Philadelphia. Dr. ...
(Date:3/31/2015)... Dr. Uzma Parvez is having a busy ... conducted Grand Grounds Presentations at St. Michael’s Medical Center for ... Effects”. The event was attended by a large gathering ... positive feedback from the Grand Rounds. It was said ... in a while. , Ahead, Dr. Parvez has been ...
Breaking Medicine News(10 mins):Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:OnChip Introduces Low Voltage Diodes for High-Brightness LED Protection 2Health News:Dr. Andrew Li of Warren Skin Care Center Is Celebrating 3 Years Recognized as an "NJ Top Doc" 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2
... and none other than ‘gen–present’ and ‘gen-next’ can perfectly relate ... waters continue unabated, people are caught in a frenetic pace, ... seeking newer excitement propelled by desires of a ‘picture-postcard’ life ... is unacceptable - a mute submission to the vagaries of ...
... top Australian researchers have predicted what they hope to be ... transform the way patients are treated, within a period of ... have little choice but to take preventive action when faced ... John Shine, the executive director of the Garvan Institute of ...
... and Locker, Inc. conducted a voluntary recall of over 5,000 ... to alert consumers //of probable beef contamination that was processed ... President Jim Goeser said, "We should note that we have ... certified lab but the voluntary recall must proceed." ,It ...
... Pittsburgh by a team of scientists to study the people aged ... of their long life and to develop tactics to conquer the ... people. ,"The longer we wait, the more they're going ... Coles, the foundation's treasurer and a researcher who has studied the ...
... first death caused by dengue fever in Andhra Pradesh. ... of the state. ,Venkateswara Rao, director (medical ... Puttaparthi in Anantapur district. Two cases in Hyderabad, one ... dengue cases. ,Unofficial reports from different parts ...
... mental fog and forgetfulness and can no longer explain it ... new UCLA study shows that chemotherapy causes changes to the ... 10 years after treatment. Reported Oct. 5 in the online ... findings may help to explain the disrupted thought processes and ...
Cached Medicine News:Health News:Mental Health: Mind at Peace or in Pieces? 2Health News:Mental Health: Mind at Peace or in Pieces? 3Health News:Mental Health: Mind at Peace or in Pieces? 4Health News:Genetics to bring about Medical Breakthroughs 2Health News:Precautionary Recall of Beef over E.coli Contamination Concerns 2Health News:Supercentenarian Center to study longevity 2Health News:First confirmed Dengue death in Andhra Pradesh 2Health News:Chemotherapy's Effects on the Brain 2Health News:Chemotherapy's Effects on the Brain 3
Instrument set for carpal tunnel release....
Standard arthroscopy graspers for small joints. Also available are Mosquito Tip Graspers, 45 degree Forceps, SquareTrimmer Blunt Tip Forceps and SST Scoop Tip Forceps....
... SR™ Hand Implant System utilizes the same ... joint replacements. The SR™ Hand Implant ... other prostheses including minimal bone resection, surface ... articular surfaces, retention and/or repositioning of the ...
The efficient choice for small joint replacement technology -- the Ascension Silicone MCP features a similar design to our PyroCarbon MCP and utilizes the same instrumentation for intra-operative fle...
Medicine Products: